U.S. flag

An official website of the Department of Health & Human Services

AHRQ: Agency for Healthcare Research and Quality

Substance Use Tools & Resources   

Read the Guide

This collection of tools and resources is for providers, staff, and patients who offer or use services to address substance use, and other interested stakeholders. This collection was originally established following an environmental scan on implementing medication-assisted treatment (MAT) for opioid use disorder (OUD) in rural primary care. (See PDFs of Volume 1 (PDF - 609 KB) and Volume 2 (PDF - 1.3 MB) of that scan). Items have been continuously added to this collection since then, and the collection has expanded to cover substance use more broadly, rather than just MAT for OUD.

Displaying 91 - 100 of 107

Fact Sheet: Fentanyl Testing to Prevent Overdose (PDF - 262 KB KB)

A fact sheet which includes information about fentanyl for both people who use drugs and Healthcare providers.

Format
Fact Sheet/Brochure
Audience
Medical Providers
Behavioral Health Providers
Patients
Other Team Members
Families
Source
Office of AIDS - California Department for Public Health (CDPH)
Year
Resource Type
PDF

Reducing Risk of Misuse and Diversion (PDF - .43 MB KB)

Describes strategies to help reduce the potential for misuse or diversion of medication for SUD treatment.

Format
Fact Sheet/Brochure
Audience
Medical Providers
Other Team Members
Source
Addiction Technology Transfer Center Network
Year

Safer-Use Strategies: Uppers/Stimulants (PDF - 80.2 KB KB)

Tips to help people stay safer and healthier no matter how they choose to change your use.
Format
Instrument/Protocol
Audience
Communities
Patients
Source
The Harm Reduction Research and Treatment (HaRRT) Center at the University of Washington
Year
Resource Type
PDF

Diversion and Abuse of Buprenorphine

Provides a high-level overview of the potential for buprenorphine abuse and how to reduce the risks.
Format
Fact Sheet/Brochure
Audience
Medical Providers
Source
Providers Clinical Support System
Year

Drug Safety Communications - FDA warns about dental problems with buprenorphine medicines dissolved in the mouth to treat opioid use disorder and pain

This is an FDA warning that dental problems have been reported with medicines containing buprenorphine that are dissolved in the mouth. Despite these risks, buprenorphine is an important treatment option for opioid use disorder (OUD) and pain, and the benefits of these medicines clearly outweigh the risks.
Format
Web Page
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Patients
Families
Communities
Source
U.S. Food & Drug Administration (FDA)
Year
Resource Type
Web Page

Opioid Use and Opioid Use Disorder in Pregnancy

This is an opinion piece that provides background, recommendations, and conclusions for the treatment of pregnant women with opioid use and opioid use disorder, to improve maternal and infant outcomes.

Format
Report/Paper/Issue Brief
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
States
Communities
Source
American College of Obstetricians and Gynecologists (ACOG)
Year
Resource Type
Web Page

Pain Management and the Opioid Epidemic: Balancing Societal and Individual Benefits and Risks of Prescription Opioid Use (PDF - 11.2 MB KB)

This guideline updates the state of the science on pain research, care, and education with a particular focus on informing the Food and Drug Administration's (FDA's) development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.
Format
Guide
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Policymakers and Payers
Source
The National Academies of Sciences, Engineering, and Medicine
Year
Resource Type
PDF